JPMorgan BetaBuilders U.S. Small Cap Equity Fund (BBSC)
NYSEARCA: BBSC · Real-Time Price · USD
63.12
-0.51 (-0.79%)
Mar 25, 2025, 4:00 PM EST - Market closed
-0.79% (1D)
| Assets | $491.87M |
| Expense Ratio | 0.09% |
| PE Ratio | 18.05 |
| Shares Out | 7.95M |
| Dividend (ttm) | $0.84 |
| Dividend Yield | 1.33% |
| Ex-Dividend Date | Mar 25, 2025 |
| Payout Ratio | 25.08% |
| 1-Year Return | +2.97% |
| Volume | 302 |
| Open | 63.22 |
| Previous Close | 63.63 |
| Day's Range | 63.04 - 63.35 |
| 52-Week Low | 57.36 |
| 52-Week High | 75.29 |
| Beta | 1.15 |
| Holdings | 787 |
| Inception Date | Nov 16, 2020 |
About BBSC
Fund Home PageThe JPMorgan BetaBuilders U.S. Small Cap Equity Fund (BBSC) is an exchange-traded fund that mostly invests in small-cap stocks. The fund tracks a market-cap-weighted index of US small cap companies. BBSC was launched on Nov 16, 2020 and is issued by JPMorgan Chase.
Asset Class Equity
Category Small Blend
Region North America
Stock Exchange NYSEARCA
Ticker Symbol BBSC
ETF Provider JPMorgan Chase
Index Tracked Morningstar US Small Cap Target Market Exposure Extended Index
Top 10 Holdings
4.36% of assets| Name | Symbol | Weight |
|---|---|---|
| JPMORGAN US GOVT MMKT FUN | n/a | 0.53% |
| Dutch Bros Inc. | BROS | 0.53% |
| Brinker International, Inc. | EAT | 0.46% |
| Credo Technology Group Holding Ltd | CRDO | 0.46% |
| TG Therapeutics, Inc. | TGTX | 0.41% |
| Hims & Hers Health, Inc. | HIMS | 0.40% |
| Corcept Therapeutics Incorporated | CORT | 0.40% |
| Rubrik, Inc. | RBRK | 0.39% |
| Chewy, Inc. | CHWY | 0.39% |
| ACI Worldwide, Inc. | ACIW | 0.39% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 25, 2025 | $0.11649 | Mar 27, 2025 |
| Dec 24, 2024 | $0.3395 | Dec 27, 2024 |
| Sep 24, 2024 | $0.20494 | Sep 26, 2024 |
| Jun 25, 2024 | $0.18033 | Jun 27, 2024 |
| Mar 19, 2024 | $0.15242 | Mar 22, 2024 |
| Dec 19, 2023 | $0.35831 | Dec 22, 2023 |
News
Why Is The IPO Market Struggling? Here's What Active Managers Have To Say
Strong returns in U.S. stocks, particularly over the past two plus years, have led investors to question the relative lack of companies going public via the IPO process — as well as the potential impl...
14 days ago - Seeking Alpha
Tech IPOs Poised For Return To Pre-Pandemic Normalcy In 2025
The new year is poised for a resurgence in tech IPOs, as lower interest rates and an investor shift to small- and mid-cap companies combine to create a more welcoming market for debuts. The current en...
3 months ago - Seeking Alpha
